EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Sleep Apnea and Stroke

Laavanya Dharmakulaseelan, Mark I Boulos

CHEST · 2024-10 · 166 (4) · 857-866

DOI: 10.1016/j.chest.2024.04.028 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift CHEST, 2024-10. Verfasst von Laavanya Dharmakulaseelan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Neurology, Sunnybrook Health Sciences Centre, and University of Toronto, Toronto, ON, Canada; Hurvitz Brain Scien…. Hauptthemen laut MEDLINE: Stroke, Sleep Apnea, Obstructive. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TOPIC IMPORTANCE: Stroke is the second-leading cause of death worldwide. OSA is an independent risk factor for stroke and is associated with multiple vascular risk factors. Poststroke OSA is prevalent and closely linked with various stroke subtypes, including cardioembolic stroke and cerebral small vessel disease. Observational studies have shown that untreated poststroke OSA is associated with an increased risk of recurrent stroke, mortality, poorer functional recovery, and longer hospitalizations. REVIEW FINDINGS: Poststroke OSA tends to be underdiagnosed and undertreated, possibly because patients with stroke and OSA present atypically compared with the general population with OSA. Objective testing, such as the use of ambulatory sleep testing or in-laboratory polysomnography, is recommended for diagnosing OSA. The gold standard for treating OSA is CPAP therapy. Randomized controlled trials have shown that treatment of poststroke OSA using CPAP improves nonvascular outcomes such as cognition and neurologic recovery. However, findings from randomized controlled trials that have evaluated the effect of CPAP on recurrent stroke risk and mortality have been largely negative. SUMMARY: There is a need for high-quality randomized controlled trials in poststroke OSA that may provide evidence to support the utility of CPAP (and/or other treatment modalities) in reducing recurrent vascular events and mortality. This goal may be achieved by examining treatment strategies that have yet to be trialed in poststroke OSA, tailoring interventions according to poststroke OSA endotypes and phenotypes, selecting high-risk populations, and using metrics that reflect the physiologic abnormalities that underlie the harmful effects of OSA on cardiovascular outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StrokeSleep Apnea, ObstructiveHumansRisk FactorsContinuous Positive Airway PressurePolysomnography

Stichwörter der Autor:innen

CPAPOSAischemic strokesleepsleep-disordered breathingstroke

Autor:innen und Institutionen

  • Department of Medicine, Division of Neurology, Sunnybrook Health Sciences Centre, and University of Toronto, Toronto, ON, Canada; Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, Sunnybrook Health…

Zitieren

APA

Dharmakulaseelan, L., & Boulos, M. I. (2024). Sleep Apnea and Stroke. CHEST, 166(4), 857-866. https://doi.org/10.1016/j.chest.2024.04.028

Vancouver

Dharmakulaseelan L, Boulos MI. Sleep Apnea and Stroke. CHEST. 2024;166(4):857-866. doi:10.1016/j.chest.2024.04.028

BibTeX
@article{Dharmakulaseelan2024,
  author = {Dharmakulaseelan, Laavanya and Boulos, Mark I},
  title = {Sleep Apnea and Stroke},
  journal = {CHEST},
  year = {2024},
  volume = {166},
  number = {4},
  pages = {857--866},
  doi = {10.1016/j.chest.2024.04.028}
}
Kostenlos starten →